Related Experiment Video
Updated: May 31, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
What's new in stroke? The top 10 studies of 2009-2011: part II
Robert G Hart1, Wiesław J Oczkowski
1Vascular Neurology, Department of Neurology, University of Texas Health Science Center, San Antonio, United States. hartr@uthscsa.edu
Insights
Novel anticoagulants like dabigatran and apixaban show promise for preventing strokes in atrial fibrillation (AF) patients. Carotid stenting risks vary by age compared to endarterectomy, requiring further long-term outcome analysis.
Area of Science:
- Cardiology
- Neurology
- Vascular Surgery
Background:
- Atrial fibrillation (AF) and cervical carotid artery stenosis are significant risk factors for stroke.
- Optimizing stroke prevention strategies is crucial for patient outcomes.
Purpose of the Study:
- To review recent evidence on stroke prevention in patients with AF and cervical carotid artery stenosis.
- To evaluate the efficacy and safety of novel oral anticoagulants and antiplatelet therapies for AF stroke prevention.
- To compare the risks of carotid artery stenting versus endarterectomy.
Main Methods:
- Review of five key studies published between 2009 and 2011.
- Analysis of two large phase III randomized trials (RE-LY, AVERROES) on novel oral anticoagulants in AF.
- Evaluation of one trial (ACTIVE A) on dual antiplatelet therapy in AF.
- Assessment of two large randomized trials (CREST, ICSS) comparing carotid stenting and endarterectomy.
Main Results:
- Dabigatran was superior to warfarin for stroke prevention in AF; apixaban was superior to aspirin in warfarin-ineligible patients. Major bleeding rates were similar for novel anticoagulants.
- Dual antiplatelet therapy (clopidogrel plus aspirin) improved stroke prevention in AF but increased major bleeding.
- Carotid stenting showed higher periprocedural stroke rates than endarterectomy, particularly in patients over 70.
Conclusions:
- Novel oral anticoagulants offer effective stroke prevention for AF patients with acceptable bleeding risk.
- Dual antiplatelet therapy may be considered for select AF patients but carries increased bleeding risks.
- Carotid stenting and endarterectomy have comparable short-term risks in younger patients, but long-term data are needed for definitive comparison, especially for older individuals.
Abstract:
Five studies published between 2009 and 2011 are reviewed that importantly inform stroke prevention for patients with atrial fibrillation (AF) or with cervical carotid artery stenosis. Two large, phase III randomized trials tested novel oral anticoagulants for stroke prevention in patients with AF: the direct thrombin inhibitor dabigatran 150 mg twice daily was superior to adjusted-dose warfarin (RE-LY trial) and the direct factor Xa inhibitor apixaban was far superior to aspirin in patients deemed unsuitable for warfarin (AVERROES trial). For both novel anticoagulants, major bleeding rates were similar to the comparator treatment. Clopidogrel plus aspirin was more efficacious than aspirin alone for prevention of stroke in patients with AF deemed unsuitable for warfarin, but major bleeding was significantly increased with dual antiplatelet therapy (ACTIVE A trial). Two large randomized trials (CREST, ICSS) provide the best available data on the short-term risks of carotid artery stenting vs. endarterectomy. In both trials, periprocedural stroke was more frequent with stenting than with endarterectomy, but the increased risk was largely confined to patients >70 years old. For younger patients, periprocedural risks were comparable with stenting or endarterectomy, but long-term outcomes are required to assess the relative merits of the two procedures.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
